1. Yaacov Michlin, CEO Technology Transfer: The Secret Engine Behind Israel’s Success

3. Without Technology Transfer We Would Not Have:

4. Without Technology Transfer We Would Not Have: Mobileye Pepper Hybrids Polymerico Fiber Optics Cherry Tomato Hybrids Sandisk Chip Motorola Barcode Reader NDS Smart Card

5. Israeli Tech Transfer Companies Yissum - a leading member of the ITTN * Commercializing Academic Intellectual Property Into Marketable Products * By number of available technologies

7. Dozens of Successful Israeli Start Ups Are Based On Academic Technologies

8. 15 Public Spin-Off Companies

9. Investment In Academic Research: Tomorrow’s New Technologies Investment In Early Stage Research High Risk = High Yield Early Stage Project Funding Long-Term Royalty-Based Funding Model Investment in Spin Off Companies

12. Yissum’s Biotech Product Pipeline: Vekacia ® (Novagali) Cyclokat ® (Novagali) Ladostigil (Avraham) BC819 (Biocancell) Anti Angiogenic (Tiltan) MRX4 (Morria) Acc. Levodopa (Intech) LABR-312 ( Biorest) CatioProst ® (Novagali) Protexia (Pharmathene) Apocell (Enlivex) VaxiSome® (Nasvax) EPOdure (Medgenics) AB103 (Atox Bio) Cortiject ® (Novagali) Phase I Phase II Phase III MRX6 (Morria) Acc. Zalepon (Intech) Acc. Baclofen (Intech) PRX105 (Protalix)

13. Bridging the Valley of Death Academic Grants Baby Seed Kamin/ Nofar Magneton, Incubators Independent Companies Extensive Long Term Collaboration An internal Yissum Program Such as Roche Funding through the OCS The Valley of Death Yissum’s services for the researchers – aimed at bridging the gap between academic financing and commercialization stage Direct investment in one of Yissum’s 45 spin off companies Yissumiot

15. Yaacov Michlin [email_address] Thank you